Wall Street analyst estimates for HeartSciences Inc. (HSCS): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
HeartSciences Inc. is a medical technology company dedicated to augmenting the clinical utility of electrocardiograms (ECGs) by integrating artificial intelligence (AI). The firm develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm specifically designed to detect impaired cardiac relaxation or other forms of cardiac dysfunction, whether caused by heart disease or the natural aging process.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 3 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 3 |
| Avg rating (1-5) | 1.00 |
Valuation Ratios
| Price / Book | 53.02 |
| EV / EBITDA | 195.51 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $64182 | $25604 | $14373 | $5150 | $18600 | $4350 | $4319 |
| Cost of Revenue | $110287 | $44276 | $34456 | $29711 | $101214 | $129836 | $133118 |
| Gross Profit | -$46105 | -$18672 | -$20083 | -$24561 | -$82614 | -$125485 | -$128799 |
| Research & Development | $2.0M | $1.7M | $3.0M | $2.5M | $2.9M | $4.4M | $2.84B |
| Selling, General & Admin | $1.7M | $841009 | $1.7M | $3.6M | $3.3M | $3.8M | $5.58B |
| Operating Expenses | $3.8M | $2.5M | $4.7M | $6.1M | $6.2M | $8.2M | $8.3M |
| Operating Income | -$3.8M | -$2.6M | -$4.7M | -$6.1M | -$6.3M | -$8.4M | -$8.4M |
| EBITDA | -$3.7M | -$2.3M | -$4.4M | -$6.1M | -$6.2M | -$8.2M | -$8.4M |
| Interest Expense | $2811 | $132454 | $371619 | $243174 | $354080 | $500453 | $753041 |
| Pre-tax Income | -$3.8M | -$2.5M | -$4.8M | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$3.8M | -$2.5M | -$4.8M | -$6.4M | -$6.6M | -$8.8M | -$9.1M |
| EPS | $-115.69 | $-77.89 | $-145.48 | $-79.92 | $-18.74 | $-9.34 | $-3.48 |
| EPS (Diluted) | $-115.69 | $-77.89 | $-145.48 | $-79.92 | $-18.74 | $-9.34 | $-3.48 |
| Shares Outstanding (Diluted) | $33138 | $33138 | $33189 | $79505 | $352520 | $938257 | $2.6M |
Price
| Price | $3.79 |
| Market Cap | $8M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AMIX · BCLI · BMRA · GBS · IBO · MTNB · MYNZ
Explore sector: Healthcare · Medical - Devices
More sections of HSCS: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks